Genetic Technologies to Wind Down U.S. ADR Program Amid ASX Trading Suspension
Genetic Technologies Stays Non‑Trading as Restructuring Under DOCA Continues
Genetic Technologies Names New Director With No Current Equity Interest
Genetic Technologies Discloses Board Exit of Director Steven Nicols
Genetic Technologies Reshapes Board With New Director Appointments and Resignations
Genetic Technologies Warrants Lapse on Expiry, Trimming Potential Dilution